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Introduction.
A fourth intracellular loop (ICL) was proposed to exist in the prototypical Gprotein coupled receptor rhodopsin after the realisation that two Cys residues in its Cterminal sequence are palmitoylated and therefore membrane-anchored (Ovchinnikov et al., 1988) . Sequence homology showed that a membrane-anchored ICL4 was likely to be common in GPCRs (Milligan et al., 1995) , including muscarinic acetylcholine receptors (mAChRs) (Hulme et al., 1990) .
Peptide competition studies were the first to show that ICL4 of rhodopsin participates in G-protein recognition (Konig et al., 1989) , while Cys-substitution mutagenesis followed by probing with a spin label indicated its involvement in the conformational change induced by photoactivation (Resek et al., 1993) . More detailed investigation showed that this conformational rearrangement occurred within a wellorganised tertiary structure (Cai et al., 1999; Altenbach et al., 1999) , and, as a by-product, identified 3 amino acids (Asn7.57, Phe7.60, Phe7.64, using the Ballesteros-Weinstein standard numbering convention) whose Cys-substitution inhibited G-protein activation.
Solution of the crystal structure of rhodopsin showed that ICL4 forms a 3-turn helix (H8) that is attached to transmembrane (TM) helix 7 by a short linker, and anchored to the cytoplasmic surface of the cell membrane by the palmitic acid moieties (Palczewski et al., 2000) . A stacking interaction occurs between the side-chains of Phe7.60 (H8) and Tyr 7.53 (TM7) which helps to constrain inactive rhodopsin to the ground state, and is broken during activation (Scheerer et al., 2008) .Mutational studies indicated that the MOL #70177 structural integrity of both of these side-chains is important for G-protein binding (Fritze et al., 2003) . H8 participates in the structural change that accompanies the activation of rhodopsin (Hoersch et al., 2008) .
H8 has also been identified in the crystal structure of squid rhodopsin (Murakami and Kouyama, 2008) and in the structures of the β 2 , β 1 adrenergic and A 2A adenosine receptors (Cherezov et al., 2007; Warne et al., 2008; Jaakola et al., 2008) , although, interestingly not in the CXCR4 receptor, which lacks the F(R/K)xx(F/L)xxH consensus sequence (Wu et al., 2010) . Mutational studies on a variety of receptors have supported the general involvement of H8 in G protein recognition (Delos Santos et al., 2006; O'Dowd et al., 1989; Sano et al., 1997; Okuno et al., 2003; Swift et al., 2006; AnaviGoffer et al., 2007) or conformational switching (Prioleau et al., 2002) . H8, in particular, a dileucine motif towards the C-terminal end, has also been implicated in control of receptor expression (Sawyer et al., 2010) , and suggested to be part of a dimerization interface involving TM1 (Fung et al., 2009) . In the M 3 mAChR, Cys-substitution and disulfide cross-linking studies indicated that the N-terminal part of H8 moves away from TM1 during agonist activation (Li et al., 2007) , and that residues in H8 can undergo both agonist independent and dependent cross-linking to Gqα (Hu et al., 2010) .
Despite this range of studies, there has been no report of a systematic and comparative evaluation of the role of residues in H8 in regulating the ligand-dependent activation of a GPCR. In this report, we have applied Ala-scanning mutagenesis to residues Asn422-Cys435 in the putative H8 sequence of the M 1 mAChR. Their location This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods.
The majority of procedures were as described in a recent publication (Lebon et al., 2009) . 
Materials. (-)-N-[
DNA and expression.
Residues Asn422-Cys 435 of the rat M 1 mAChR, cloned in the pCD expression vector, were mutated to Ala (GCG or GCC) by a PCR procedure;
Ala423 was mutated to Gly (GGC). Mutant sequences were verified by di-deoxy sequencing (Co-Genics) before transient expression in COS-7 cells grown in minimal essential medium-α supplemented with 10 % newborn calf serum and 1% glutamate plus antibiotics at 37°C in 5% CO 2 (Lebon et al., 2009) . The medium was changed after 24 h and the cells grown for a further 48 h before assay or harvesting. In some experiments, the media were supplemented with atropine (10 -6 M) after 24 h to rescue the low expressing mutant N422A, as described previously (Lu and Hulme, 1999; Bee and Hulme, 2007) . Membrane protein concentrations were measured using the micro BCA assay with bovine serum albumin as standard.
This article has not been copyedited and formatted. The final version may differ from this version. were analysed by least squares fitting using SigmaPlot 10. Radioligand saturation curves were fitted to a depletion-corrected 1-site binding model, yielding a pK d value, and an estimate of the total number of binding sites present in the assay, R T . The mean expression level of the wild-type receptor was 2.9 ± 1.5 pmol/mg protein (mean ± S.D.).
Simultaneous ACh competition curves were globally fitted to an allosteric ternary complex model with the cooperativity parameter set to 10 -6 representing competitive interactions between [ 3 H]NMS and ACh as previously described (Lebon et al., 2009) .
These analyses yielded a pK d value, and a slope factor, usually ca. 0.8. for ACh.
Radioligand dissociation data were fitted to a single exponential, as described previously (Goodwin et al., 2007) , to estimate a dissociation rate constant.
This article has not been copyedited and formatted. The final version may differ from this version. PI dose-response curves were fitted to a 4-parameter logistic function yielding, for each ligand, a pEC 50 , a slope factor (close to 1), a Basal value, and a maximal response, which was designated R Max, A, R Max, P, R Max, N as appropriate for each of the three ligands.
The maximum signal elicited by ACh and pilocarpine was calculated relative to the signal (defined as the zero signal) measured in the presence of a maximally-effective concentration of the inverse agonist, NMS:
The basal signal was also calculated relative to the zero signal
For each set of dose-response curves, the ratios of the maximal to the zero signals were then calculated; in principle, these ratios should not be sensitive to variations in the cell density, and extent of labelling of the phosphoinositide pool. The ratio of the pilocarpine maximum signal to the corresponding ACh maximum signal, a measure of pilocarpine signalling efficacy, was then calculated as e P = r P /r A The basal signal elicited by the wild-type and mutant receptors was calculated as a fraction of the maximum ACh-induced response
The signalling efficacy of ACh was calculated using a previously-published expression (Lu and Hulme, 1999 ) relative to an expected value such as 1.0, were assessed using Student's t-test.
Construction of a molecular model of the M 1 mAChR. The trans-membrane domain of the M 1 mAChR was initially modelled on the structure of the high-resolution X-ray crystal structure of the human β 2 -adrenergic receptor (pdb code 2RH1: (Cherezov et al., 2007) ). This was highly similar to our previous model (Lu et al., 2001 ) based on the structure of bovine rhodopsin (pdb code 1F88: (Palczewski et al., 2000) ) in terms of the relative orientation of the seven transmembrane helices. However, the conformation of on significant sequence homology to ICL3 from the structure of squid rhodopsin (pdb code 2Z73: (Murakami and Kouyama, 2008) ) which is also Gq-coupled and mediates PI breakdown.
This article has not been copyedited and formatted. The final version may differ from this version. These data are summarised in Supplemental Table 2 .
In the case of N422A, the expression of specific [ 3 H]NMS binding sites was reduced to ca. 7% of the value of wild-type controls. As reported for other mutations that adversely effect expression levels (Lu and Hulme, 1999; Lu et al., 2001; Bee and Hulme, 2007) Downloaded from 10 -6 M atropine for 48 h before harvesting, the specific activity increasing from 6 % to 62 % of a co-transfected WT control for the experiment shown in Fig. 1a . Overall, the mean estimate of the specific activity of N422A in membranes from atropine-pre-treated cells was somewhat lower, 34% of the mean specific activity of the wild-type receptor. (Lu and Hulme, 1999) . Most mutations failed to affect the equilibrium affinity of ACh. However, R426A
and L434A elicited ca. 3-fold reductions while F429A caused a 3-fold increase in ACh affinity (Fig 2a) , ACh, a partial agonist, Pilocarpine, and an inverse agonist, NMS, were measured in each experiment. The response in the presence of a receptor-saturating concentration of NMS was used to define the background level. The data set is summarised in Supplemental Table 4 .
As shown in Fig. 4a , ACh elicited a robust PI response from the wild-type M 1 mAChR, with a ratio of stimulated to background signalling of 4-7-fold, and a pEC 50 of 7.60 ± 0.38 (mean ± S.D.). Pilo elicited a similar maximum response, with a pEC 50 of 6.08 ± 0.24 (mean ± S.D.). The potencies are in good agreement with previous findings (Page et al., 1995) , although in the present experiments, Pilo elicited a maximum response equivalent to that of ACh from the wild-type receptor. The inverse agonist NMS inhibited the basal response of the wild-type receptor by ca. 30 % (Fig. 4a) .The mean of the NMS-inhibited signal was ca. 13.5 % when expressed as a fraction of the AChstimulated maximum signal and the pIC 50 for NMS was 9.0. A similar effect has been described previously (Goodwin et al., 2007) .
While none of the mutations significantly altered the maximum response to ACh relative to a contemporaneous wild-type control, five of them, F425A, R426A, D427A, T428A and L432A significantly reduced the potency of ACh, the effect ranging from 6.3-fold (D427A) to 31-fold (T428A) (Fig. 2b, Fig. 4b,c) . Four of the five, the exception being D427A, also reduced the potency of Pilo to a similar extent (Fig. 2c, Fig. 4b,c) , and three of these additionally reduced e P , the maximum signal elicited by Pilo relative to This article has not been copyedited and formatted. The final version may differ from this version. respectively. In contrast, F429A increased the NMS-inhibited basal activity about 2-fold ( Fig. 4d ) without any significant change in agonist potencies, or the maximum response.
The potency of a full agonist, such as ACh, is dependent on three factors: the binding affinity, the expression level of the receptor relative to the G protein to which it couples and the signalling efficacy, e A , of the agonist-receptor complex for the coupled G protein. We have shown that, when the mutation does not reduce the maximum AChstimulated response, it is possible to estimate e A by combining the signalling, binding and receptor expression parameters using the equation described in materials and methods (Lu and Hulme, 1999) . The results are plotted in Fig. 5a , and summarised in Supplemental Table 4 .
We have suggested previously that, given the multifactorial nature of e A , changes should exceed 5-fold to be considered functionally significant. Four of the mutations that reduced ACh potency met this criterion, F425A, R426A, T428A and L432A, with reductions ranging from 6-18-fold. In addition, F429A showed a reduction in e A approaching 10-fold, reflecting the finding that its signalling potency failed to increase in parallel with its binding affinity. F425A, R426A and T428A showed parallel decreases in This article has not been copyedited and formatted. The final version may differ from this version. e P , the maximum Pilo signal relative to that of ACh (Fig. 5b) . L432A showed a similar trend, but the change failed to reach statistical significance.
Modelling of the M 1 mAChR.
A model of the trans-membrane domain of the M 1 mAChR was built by homology with the high-resolution crystal structure of the human β 2 -adrenergic receptor. Details of the procedure are described in Materials and Methods.
Differences to our earlier rhodopsin-based model (Lu et al., 2001) included the remodelling of ECL2 in a more "open" conformation, while retaining the cis-disulfide bond between Cys98 (TM3) and Cys178, and refinement of ECL3 on the basis of the corresponding loop in the extracellular domain of the A 2A adenosine receptor, which contains a homologous pair of Cys residues that are disulfide bonded (Jaakola et al., 2008) . ICL3 incorporated a revised truncation (Δ 225-239) designed to retain homologous sequences found in squid rhodopsin, where they form extensions of TM5 and TM6 that may participate in Gq recognition (Murakami and Kouyama, 2008) .
A key difference between our revised model of the M 1 mAChR and the original model based on the structure of rhodopsin concerns potential interactions between Tyr 418 (7.53) and Phe425 (7.60 ). In the ground state structure of bovine rhodopsin, the sidechain of Tyr7.53 is rotated towards the intracellular surface to form a microdomain in which the aromatic ring stacks with the side-chain of Phe7.60 (Palczewski et al., 2000) .
In contrast, in squid rhodopsin (Murakami and Kouyama, 2008) (Lu et al., 2002) , as in ground state bovine rhodopsin (Fig. 7a) , the postulated aromatic stacking interaction also sequesters and restricts the side-chain of Phe7.60. In contrast, in the revised model of M 1 (Fig. 7b) , like the β 2 adrenoceptor and the active structure of opsin (Fig. 7c) , the side-chain of Phe 7.60 rotates outward about the Cα-Cβ bond, and so becomes accessible to approach from the cytoplasmic surface of the receptor. Related to this conformational difference, in the rhodopsin-based model of M 1 , as in rhodopsin itself, the last turn of TM7 corresponding to Ala419 (7.54) -Asn422 (7.57) is substantially unwound. In contrast, in the β 2 adrenoceptor-based model the corresponding residues are more tightly wound, forming an additional helical turn. This brings the amide side-chain of Asn422 into close proximity to the main chain carbonyl group of Ala419, forming a C-cap to TM7 (Fig. 6b) . This facilitates the tight turn that allows H8 to depart in an orthogonal direction, emulating the role of Pro330 in the β
Discussion.
The phenotypes of Ala-substitution mutations provide insight into the functional role of the targetted side-chain within the receptor structure Bee and Hulme, 2007) . H8 is remote from the ligand binding site of the M 1 mAChR, and has limited potential for interactions with the core of the transmembrane domain. Only one mutation, N422A, had a destabilising effect on the receptor structure, reflected in a strongly lowered receptor expression level that could be rescued by the pharmacological chaperone effect of atropine. Similarly, there were only limited effects on the equilibrium binding affinity of NMS and ACh, or on the kinetics of NMS binding.
In a study of TM7, we found that the Ala-substitution of Tyr418 (7.53) in the NPXXY switch motif, in addition to causing a large reduction in signalling efficacy, also strongly (30-fold) enhanced ACh affinity, consistent with the ablation of a key intramolecular contact that stabilises the inactive ground state as opposed to the AChactivated state of the receptor (Lu et al., 2001) . Molecular modelling based on the ground-state structure of bovine rhodopsin suggested that this contact might be with the aromatic ring of Phe425 (7.60) (Lu et al., 2002) . However, the absence of any corresponding increase in ACh affinity in the F425A mutant suggests that this stacking contact does not exist in the unliganded M 1 mAChR. Indeed, it has not been found in the crystal structures of the antagonist complexes of the β 1 and β 2 adrenoceptors, the A 2A adenosine receptor, and squid rhodopsin; in all of these structures, Tyr7.53 is in a different rotameric state to that found in bovine rhodopsin. Interestingly, the F429A This article has not been copyedited and formatted. The final version may differ from this version. The locations of the residues mutated in this study are indicated in the scheme shown in Fig. 6a . A molecular model of the TM domain and H8 of the M 1 mAChR based on homology to the β 2 -adrenergic receptor and the Gq-coupled squid rhodopsin provides a plausible explanation for the roles of Asn422 and Phe429 within this sequence (Fig.   6b ). The amide group of Asn422 is hydrogen bonded to the carbonyl group of Ala419 (7.54), thus acting as a C-cap to TM7, and stabilising the turn that allows H8 to depart in a different direction. Ala-substitution of N422 would remove this H bond, destabilising the junction. Within 2.46 -2.86 Ǻ of the phenyl ring of Phe429 are the α -proton of Ala419 (7.54), the β -proton of Tyr418 (7.53) , and the hydroxyl group of Ser49 (1.56).
These contacts of Phe429 may help to restrict movements of TM7 relative to H8 in the ground state of the receptor. Activation involves a large movement of the side-chain of Tyr7.53 (Scheerer et al., 2008) . The ring of Phe429 may also be involved in building the active state conformation, as evidenced by the significant loss of ACh signalling efficacy that accompanied its Ala-substitution.
The main finding was the identification of four more residues whose Alasubstitution caused a substantial decrease in signalling efficacy, namely Phe425, Arg426, Thr428 and Leu432. The periodic variation in potency, with the effect peaking every 4 th residue (c.f. Fig. 2c ), is compatible with the proposed α -helical structure for this sequence, at least in the activated state of the receptor. In only one case, R426A, was there any measurable decrease in ACh affinity, which is thought to reflect perturbation of the G protein independent ground state. Thus, their phenotype suggests that these residues may be directly involved in Gq binding in the agonist-induced signalling state of the M 1 mAChR. It should be noted, however, that the maximum effect on efficacy, 18-fold, was significantly less than the 100-fold decrease that resulted from the mutation of the conserved Arg3.50 that is thought to play a critical part in anchoring the C-terminus of the G protein Scheerer et al., 2008) . Interestingly, Ala-substitution of the putatively palmitoylated Cys432 did not affect signalling. A similar observation has been made for Ser substitution of this residue (Savarese et al., 1992) .
Mapping these residues onto the model of the M 1 mAChR shows that three of them, Phe425 (7.60), Thr428 (7.63) and Leu432 (7.67) are located on sequential turns in one quadrant of H8, with their side-chains projecting parallel to the plane of the lipid bilayer along a vector oriented towards TM1, while the fourth, Arg426 (7.61) is on the opposite, outward, face of the helix (Fig. 7b) . Also shown in the model are the locations of the M 1 mAChR residues homologous to the contact residues for the C-terminal peptide of Gtα in the crystal structure of its complex with "activated" acid opsin (Scheerer et al., 2008) , as well as the "ionic lock" residues Arg3.50 and Glu6.30.
In the ground state of rhodopsin (Li et al., 2004) , Phe7.60 is stacked with, and restricts, Tyr7.53. Similarly, the other G-protein recognition residues are held in a compact configuration by the ionic lock (Fig. 7a) . Interestingly, in contrast to the M 1 This article has not been copyedited and formatted. The final version may differ from this version. mAChR, rhodopsin has no detectable basal signalling activity (Hofmann et al., 2009) . In the "active" Gtα-opsin complex the ionic lock is broken, allowing TM6 to rotate and swing out (Fig. 7c) . The contact between Phe7.60 and Tyr7.53 is broken, allowing the side-chain of the latter to swing round to underpin the key contact made by Arg3.50 with a β -turn near the C-terminus of the Gtα peptide, and H8 rotates around an axis normal to the plane of the membrane. The recognition residues in TM5 and 6 click into register with the H8 residues to form an extended surface for G protein recognition. According to this view, the unliganded M 1 mAChR exists in an intermediate, partly activated, conformation, which is consistent with its possession of significant basal signalling activity.
That agonist binding induces a conformational change involving H8 was suggested by a Cys-substitution and induced disulfide-cross-linking study on the M 3 mAChR (Li et al., 2007) . Increased spatial separation or conformational mobility between the N-terminal segment of H8 and TM1 is a favoured interpretation. An extension of this study demonstrated facile cross linking of Cys residues substituted for the last three amino acids of Gq to M 3 mutants at positions corresponding to Lys423 (7.58), Ala424 (7.59), Asp427 (7.62) and Leu431 (7.66) , which are adjacent to the signaltransduction critical positions that we have identified (Fig. 6a ), but instead point directly into the cytoplasm (Hu et al., 2010) . Cross-linking was particularly strong at positions 7.62 and 7.66, and was independent of agonist activation. In contrast, agonist-dependent cross-links were formed between the C-terminal residues of Gq and a position in TM6
This article has not been copyedited and formatted. The final version may differ from this version. previously demonstrated to be involved in G protein specificity (Blin et al., 1995) , as well as between a residue in the α 4-β6 loop of Gq and positions 7.58, 7.59 and 7.62 in H8.
Based on these studies, an attractive hypothesis is that the membrane-associated H8 helix acts as an initial docking station for the C-terminal helix of Gq when an encounter complex is formed between the receptor and the membrane-anchored G protein This article has not been copyedited and formatted. The final version may differ from this version. Wild-type and mutant rat M 1 mAChRs were transiently expressed in COS-7 cells.
Changes relative to wild-type are displayed on a log scale and are shown as mean ± SEM.
The full data set is given in Supplemental Tables 3 and 4.* P<0.05, ** P<0.01 with respect to wild-type. 
